Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease

Relation of Aspirin Response to Age in Patients With Stable Coronary Artery Disease

(2013) Mordehay Vaturi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease

(2013) Sanne Larsen et al.   THROMBOSIS AND HAEMOSTASIS

A contemporary viewpoint on ‘aspirin resistance’

(2012) Nadzeya Kuzniatsova et al.   ANNALS OF MEDICINE

Aspirin Resistance: Current Status and Role of Tailored Therapy

(2012) Jonathan Grinstein et al.   CLINICAL CARDIOLOGY

Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease

(2012) Jose Luis Ferreiro et al.   CURRENT PHARMACEUTICAL DESIGN

Interindividual Variability in the Efficacy of Oral Antiplatelet Drugs: Definitions, Mechanisms and Clinical Importance

(2012) Morten Wurtz et al.   CURRENT PHARMACEUTICAL DESIGN

Antiplatelet Therapy in Patients with Diabetes Mellitus

(2012) Erik L. Grove et al.   Current Vascular Pharmacology

Effect of different anticoagulants on multiple electrode platelet aggregometry after clopidogrel and aspirin administration in patients undergoing coronary stent implantation: A comparison between citrate and hirudin

(2012) Hong-Zhe Zhang et al.   PLATELETS

Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction

(2012) Sanne Larsen et al.   THROMBOSIS AND HAEMOSTASIS

High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study

(2011) J. Silvain et al.   EUROPEAN HEART JOURNAL

Which is the best anticoagulant for whole blood aggregometry platelet function testing? Comparison of six anticoagulants and diverse storage conditions

(2011) Andreas Friedrich Christoph Kaiser et al.   PLATELETS

Platelet aggregation is dependent on platelet count in patients with coronary artery disease

(2011) Morten Würtz et al.   THROMBOSIS RESEARCH

Influence of renal function and platelet turnover on the antiplatelet effect of aspirin

(2011) Morten Würtz et al.   THROMBOSIS RESEARCH

Effect of Obesity on the Pharmacokinetics of Drugs in Humans

(2010) Michael J. Hanley et al.   CLINICAL PHARMACOKINETICS

Patients With Previous Definite Stent Thrombosis Have a Reduced Antiplatelet Effect of Aspirin and a Larger Fraction of Immature Platelets

(2010) Morten Würtz et al.   JACC-Cardiovascular Interventions

The role of weight and enteric coating on aspirin response in cardiovascular patients

(2010) A. PEACE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease

(2010) E. L. GROVE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease

(2010) Anne-Mette Hvas et al.   THROMBOSIS AND HAEMOSTASIS

Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus

(2010) S.B. Mortensen et al.   THROMBOSIS RESEARCH

Existing data sources for clinical epidemiology: The Western Denmark Heart Registry

(2010) Morten Schmidt   Clinical Epidemiology

Relation of Body Mass Index to High On-Treatment Platelet Reactivity and of Failed Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients Undergoing Percutaneous Coronary Intervention

(2009) Nathalie Bonello-Palot et al.   AMERICAN JOURNAL OF CARDIOLOGY

Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology

(2009) W. Kuliczkowski et al.   EUROPEAN HEART JOURNAL

Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin

(2009) Marie Lordkipanidzé et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Platelet Inhibition by Aspirin 81 and 325 mg/day in Men Versus Women Without Clinically Apparent Cardiovascular Disease

(2008) Rehan Qayyum et al.   AMERICAN JOURNAL OF CARDIOLOGY